Medicure (MCUJF) Cash from Investing Activities (2010 - 2026)

Medicure's Cash from Investing Activities history runs 15 years deep, the most recent figure standing at -$278556.6 for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 26.25% year-over-year to -$278556.6; the TTM figure through Mar 2026 stood at -$1.4 million (down 60.63% YoY), while the FY2025 annual figure was -$1.5 million, down 176.8% from the prior year.
• Cash from Investing Activities was -$278556.6 for Q1 2026 at Medicure, down from $96806.6 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $96806.6 in Q4 2025 to a low of -$1.2 million in Q2 2025.
• Historically, Cash from Investing Activities has averaged -$203051.1 across 5 years, with a median of -$89901.3 in 2023.
• Biggest YoY gain for Cash from Investing Activities was 130.19% in 2025; the steepest drop was 1451.84% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at -$206254.7 in 2022, then soared by 54.42% to -$94020.5 in 2023, then slumped by 241.1% to -$320700.4 in 2024, then soared by 130.19% to $96806.6 in 2025, then sank by 387.75% to -$278556.6 in 2026.
• The last three Cash from Investing Activities figures came in at -$278556.6 (Q1 2026), $96806.6 (Q4 2025), and -$1.2 million (Q2 2025), per Business Quant data.